Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

biote Corp. (BTMD)

5   -0.12 (-2.34%) 10-02 16:00
Open: 5.08 Pre. Close: 5.12
High: 5.08 Low: 4.985
Volume: 92,555 Market Cap: 363(M)

Technical analysis

as of: 2023-10-02 3:48:23 PM
Short-term rate:       
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Mid-term rate:       
Target: Six months: 6.16     One year: 6.51
Support: Support1: 4.78    Support2: 3.97
Resistance: Resistance1: 5.27    Resistance2: 5.57
Pivot: 5.23
Moving Average: MA(5): 5.25     MA(20): 5.17
MA(100): 5.85     MA(250): 5.12
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 36.1     %D(3): 53.6
RSI: RSI(14): 39.8
52-week: High: 8.22  Low: 2.75
Average Vol(K): 3-Month: 157 (K)  10-Days: 77 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ BTMD ] has closed above bottom band by 12.8%. Bollinger Bands are 54.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 20 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.21 - 5.24 5.24 - 5.27
Low: 4.99 - 5.04 5.04 - 5.08
Close: 5.05 - 5.12 5.12 - 5.17

Company Description

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

Headline News

Sat, 16 Sep 2023
biote Corp. (NASDAQ:BTMD) Sees Significant Drop in Short Interest - MarketBeat

Thu, 10 Aug 2023
Biote Reports Second Quarter 2023 Financial Results - Yahoo Finance

Mon, 05 Jun 2023
Biote Announces Pricing of Secondary Offering of Common Stock - Business Wire

Tue, 30 May 2023
Biote Appoints Mary J. Puncochar as Chief Commercial Officer - Business Wire

Tue, 09 May 2023
Biote Announces Commencement of Exchange Offer and Consent ... - Business Wire

Mon, 07 Nov 2022
Biote Appoints Debby Morris to Board of Directors - citybiz

Financial Analysis

Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Outperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  PNK
Sector:  Healthcare
Industry:  Medical Care Facilities
Shares Out. 28 (M)
Shares Float 16 (M)
% Held by Insiders 16.3 (%)
% Held by Institutions 71.4 (%)
Shares Short 549 (K)
Shares Short P.Month 990 (K)

Stock Financials

EPS -0.41
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -1.67
Profit Margin (%) -5.8
Operating Margin (%) 6.6
Return on Assets (ttm) 5.9
Return on Equity (ttm) 0
Qtrly Rev. Growth 19.1
Gross Profit (p.s.) 0
Sales Per Share 6.51
EBITDA (p.s.) 0.47
Qtrly Earnings Growth 0
Operating Cash Flow 32 (M)
Levered Free Cash Flow -1 (M)

Stock Valuations

PE Ratio -12.24
PEG Ratio 0
Price to Book value -3.01
Price to Sales 0.76
Price to Cash Flow 4.31

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.